multiple sclerosis and glp 1 Can GLP-1 Drugs Aid Management? Episode 444: A GLP-1 Drug

J.BenoitS

Breaking News Merck Enters Exclusive Alliance with Hansoh Pharma for Oral GLP-1 Candidate Hansoh Pharma will receive $112 million upfront and is eligible to receive up to $1.9 billion in milestone payments

Take-Home Message: Tirzepatide continues to emerge as more than a glucose-lowering or weight-management drug it may represent the next step toward organ-protective diabetes therapy, addressing both cardiovascular and renal outcomes

Many people mistakenly assume hunger means they need larger portions immediately

The analysis found no increased incidence of gastrointestinal cancers, including colorectal cancer, compared to placebo or standard care

Therefore, this innovative and important trial design feature has the potential to extend the use of this class of medication to those with normo- or microalbuminuriaa subgroup of patients who have yet to be included in prior key kidney protection trials